Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Chubb
Cipla
Mallinckrodt
Harvard Business School
Baxter

Generated: August 19, 2019

DrugPatentWatch Database Preview

Litigation Details for King Pharmaceuticals Inc. v. Intelliject Inc. (D. Del. 2011)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

King Pharmaceuticals Inc. v. Intelliject Inc. (D. Del. 2011)

Docket   Try a Free Trial Date Filed 2011-01-19
Court District Court, D. Delaware Date Terminated 2012-03-08
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties INTELLIJECT INC.; KING PHARMACEUTICALS INC.; MERIDIAN MEDICAL TECHNOLOGIES INC.
Patents 7,449,012; 7,794,432
Attorneys Amy Arnott Quinlan; Anna Brandl; Anthoula Pomrening; Bridget E Montgomery; Eric R. Moran; Jack B. Blumenfeld; James M McCarthy; James V DeGiulio; Jeffrey D. Mills; Kenneth Laurence Dorsney; Margaret Fleming England; Mary Matterer; Mike Stenglein; Nicole E. Reifman; Paul H. Berghoff; Richard D. Kirk; Richard K. Herrmann; Rodger Dallery Smith , II; Sydney R. Kokjohn; Thomas J. Meloro
Firms Darby, Brown-Edwards LLC; Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in King Pharmaceuticals Inc. v. Intelliject Inc.
The small molecule drug covered by the patents cited in this case is   Try a Free Trial .

Details for King Pharmaceuticals Inc. v. Intelliject Inc. (D. Del. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-02-11 11 U.S. Patent No. 7,449,012 (the "'012 patent"; Exhibit 2) and the '432 patent (Exhibit…quot;) had listed its U.S. Patent No. 7,449,012 ("the '012 patent") in the FDA Approved … U.S. Patent No. 7,449,012 The '369 patent 1. An auto-injector… U.S. Patent No. 7,449,012 The '369 patent The needle cover… U.S. Patent No. 7,449,012 The '369 patent The needle cover External link to document
2011-02-15 15 because both cases involve the same patent, U.S. Patent No. 7,794,432. While defendants’ accused products…matters being related cases because many of the patent claim terms will read on the accused products in…2011 8 March 2012 1:11-cv-00065 830 Patent None District Court, D. Delaware External link to document
2011-01-19 3 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,794,432 B2;. (ksr) (Entered…2011 8 March 2012 1:11-cv-00065 830 Patent None District Court, D. Delaware External link to document
2011-04-12 30 complaints. In 09-652 you 22 see U.S. patent 7,449,012, then something B2. 23 UNIDENTIFIED…there is a common patent, and that is the, I will call it 16 the '012 patent, and the second case…case adds to that the '432 17 patent? Is that correct? 18 UNIDENTIFIED SPEAKER…SPEAKER: I believe it's the '432 19 patent that is common to both cases, Your Honor. 20 …UNIDENTIFIED SPEAKER: I believe the patent was 24 added to that case in November of last year. External link to document
2011-10-17 72 ORDER CONSTRUING THE TERMS OF U.S. PATENT NOS. 7,499,012; AND 7,794,432. Signed by Xhief Judge Gregory M…2011 8 March 2012 1:11-cv-00065 830 Patent None District Court, D. Delaware External link to document
2011-11-07 80 . Clemens Regarding Infringement of U.S. Patent No. 7,794,432 by King Pharmaceuticals Inc., Meridian Medical…2011 8 March 2012 1:11-cv-00065 830 Patent None District Court, D. Delaware External link to document
2011-11-30 81 . Clemens Regarding Infringement of U.S. Patent No. 7,794,432 by King Pharmaceuticals Inc., Meridian Medical…2011 8 March 2012 1:11-cv-00065 830 Patent None District Court, D. Delaware External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
US Department of Justice
Chinese Patent Office
McKesson
Cantor Fitzgerald
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.